Suhani Mehta Thanki, PharmD, BCOP

Stem Cell Transplant Clinical Pharmacist MD Anderson Cancer Center (@mdandersonnews) | PGY2 @ClevelandClinic and PGY1 @NorthwesternMed | Views are my own!

[Transplantation and Cellular Therapy Journal @ASTCT_Journal]

A study on septic shock after #alloHSCT finds gram-negative bacilli accounted for 61.5% of the positive isolates. Of patients with sepsis-induced coagulopathy, the 28-day mortality rate was 88.1%. https://t.co/Wmnadl0kfH

[Alison Gulbis 😷💉✌🏼 @AlisonGulbis]

Impact of Antifungal (azole vs echinocandin) during PTCy in allo SCT. Strong work! ⁦@AmyZhenggg⁩ ⁦@StemCellSuhani⁩ ⁦@MDAndersonNews⁩ #HOPA2024

[Suhani Mehta Thanki, PharmD, BCOP @StemCellSuhani]

Impact of Antifungal Use with PTCy 🔍@MDAndersonNews @AmyZhenggg @HOPArx

[Suhani Mehta Thanki, PharmD, BCOP @StemCellSuhani]

This is my fan picture 📸 that moment when you meet your favorite TikToker! Thank you for recognizing pharmacists in the way you do! So happy we were able to listen to an Incredible talk by @DGlaucomflecken at HOPA! @HOPArx

[UT MD Anderson @UTMDAnderson]

MD Anderson is again #1 in the nation for cancer care in @USNews’ “Best Hospitals” ranking: https://t.co/DpQfLjSt2G

Thanks to all who make this possible: our faculty, employees, trainees, students, volunteers, donors, advocates, partners, patients and caregivers. #BestHospitals #EndCancer

[Rahul Banerjee, MD, FACP @RahulBanerjeeMD]

When I get to clinic 3 min before my first scheduled patient of a completely booked morning clinic,

And the computer in my assigned clinic room decides to install “critical updates” as soon as I log on…

[Alison Gulbis 😷💉✌🏼 @AlisonGulbis]

MD Anderson Pharmacists were well represented this year at Tandem’s 2023 conference held in Orlando, Florida February 15-19. The following pharmacists contributed to interprofessional research: 🧵@MDAndersonNews @JiteshKawedia @StemCellSuhani @ASTCT #Tandem23 #twitterlessTL

[Suhani Mehta Thanki, PharmD, BCOP @StemCellSuhani]

Presenting my residency research project at ASTCT! Impact of Fludarabine Renal Dose Adjustments in Allogeneic Hematopoietic Cell Transplant, poster 226 #ASTCT23

[Liz Rogers @lizrogers22]

🚨🚨 📢 the data we’ve all been waiting for…drum roll please 👏👏👏 letermovir use til D+200 was shown to be safe & effective in HSCT pt post txp in recent phase 3 RCT‼️ So excited to have this extra data to support use beyond D+100 in this high risk pop! 🎉🎉🎉 #Tandem23 @ASTCT